AMN HEALTHCARE SERVICES INC (AMN)
US0017441017 - Common Stock
Overall AMN gets a fundamental rating of 5 out of 10. We evaluated AMN against 118 industry peers in the Health Care Providers & Services industry. While AMN has a great profitability rating, there are some minor concerns on its financial health. AMN is cheap, but on the other hand it scores bad on growth. With these ratings, AMN could be worth investigating further for value investing!.
1. Profitability
1.1 Basic Checks
AMN had positive earnings in the past year.
In the past year AMN had a positive cash flow from operations.
In the past 5 years AMN has always been profitable.
AMN had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
The Return On Assets of AMN (7.20%) is better than 90.60% of its industry peers.
Looking at the Return On Equity, with a value of 25.35%, AMN belongs to the top of the industry, outperforming 93.16% of the companies in the same industry.
With an excellent Return On Invested Capital value of 10.99%, AMN belongs to the best of the industry, outperforming 92.31% of the companies in the same industry.
AMN had an Average Return On Invested Capital over the past 3 years of 17.26%. This is significantly above the industry average of 8.58%.
The last Return On Invested Capital (10.99%) for AMN is well below the 3 year average (17.26%), which needs to be investigated, but indicates that AMN had better years and this may not be a problem.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.2% | ||
| ROE | 25.35% | ||
| ROIC | 10.99% |
ROA(3y)11.01%
ROA(5y)8.39%
ROE(3y)32.02%
ROE(5y)24.03%
ROIC(3y)17.26%
ROIC(5y)13.59%
1.3 Margins
With an excellent Profit Margin value of 5.56%, AMN belongs to the best of the industry, outperforming 81.20% of the companies in the same industry.
AMN's Profit Margin has declined in the last couple of years.
AMN's Operating Margin of 8.93% is amongst the best of the industry. AMN outperforms 84.62% of its industry peers.
AMN's Operating Margin has been stable in the last couple of years.
Looking at the Gross Margin, with a value of 32.98%, AMN is in the better half of the industry, outperforming 60.68% of the companies in the same industry.
In the last couple of years the Gross Margin of AMN has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 8.93% | ||
| PM (TTM) | 5.56% | ||
| GM | 32.98% |
OM growth 3Y1.49%
OM growth 5Y-1.21%
PM growth 3Y23.47%
PM growth 5Y-3.47%
GM growth 3Y-0.1%
GM growth 5Y0.23%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), AMN is creating value.
The number of shares outstanding for AMN has been reduced compared to 1 year ago.
The number of shares outstanding for AMN has been reduced compared to 5 years ago.
AMN has a worse debt/assets ratio than last year.
2.2 Solvency
AMN has an Altman-Z score of 3.10. This indicates that AMN is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of AMN (3.10) is better than 77.78% of its industry peers.
AMN has a debt to FCF ratio of 4.89. This is a neutral value as AMN would need 4.89 years to pay back of all of its debts.
AMN has a Debt to FCF ratio of 4.89. This is in the better half of the industry: AMN outperforms 76.07% of its industry peers.
A Debt/Equity ratio of 1.57 is on the high side and indicates that AMN has dependencies on debt financing.
Looking at the Debt to Equity ratio, with a value of 1.57, AMN is doing worse than 66.67% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.57 | ||
| Debt/FCF | 4.89 | ||
| Altman-Z | 3.1 |
ROIC/WACC1.5
WACC7.31%
2.3 Liquidity
AMN has a Current Ratio of 1.28. This is a normal value and indicates that AMN is financially healthy and should not expect problems in meeting its short term obligations.
AMN has a Current ratio (1.28) which is in line with its industry peers.
AMN has a Quick Ratio of 1.28. This is a normal value and indicates that AMN is financially healthy and should not expect problems in meeting its short term obligations.
With a Quick ratio value of 1.28, AMN perfoms like the industry average, outperforming 51.28% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.28 | ||
| Quick Ratio | 1.28 |
3. Growth
3.1 Past
AMN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -31.14%.
Measured over the past years, AMN shows a quite strong growth in Earnings Per Share. The EPS has been growing by 19.92% on average per year.
The Revenue for AMN has decreased by -27.73% in the past year. This is quite bad
Measured over the past years, AMN shows a quite strong growth in Revenue. The Revenue has been growing by 12.15% on average per year.
EPS 1Y (TTM)-31.14%
EPS 3Y33.37%
EPS 5Y19.92%
EPS growth Q2Q-46.77%
Revenue 1Y (TTM)-27.73%
Revenue growth 3Y16.55%
Revenue growth 5Y12.15%
Revenue growth Q2Q-27.3%
3.2 Future
AMN is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 0.00% yearly.
Based on estimates for the next years, AMN will show a decrease in Revenue. The Revenue will decrease by -0.20% on average per year.
EPS Next Y-50.93%
EPS Next 2Y-23.45%
EPS Next 3Y-13.49%
EPS Next 5Y0%
Revenue Next Year-15.46%
Revenue Next 2Y-6.29%
Revenue Next 3Y-3.74%
Revenue Next 5Y-0.2%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 7.30, the valuation of AMN can be described as very cheap.
Compared to the rest of the industry, the Price/Earnings ratio of AMN indicates a rather cheap valuation: AMN is cheaper than 96.58% of the companies listed in the same industry.
AMN is valuated cheaply when we compare the Price/Earnings ratio to 28.28, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 14.87, AMN is valued correctly.
Compared to the rest of the industry, the Price/Forward Earnings ratio of AMN indicates a somewhat cheap valuation: AMN is cheaper than 77.78% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 20.88. AMN is valued slightly cheaper when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 7.3 | ||
| Fwd PE | 14.87 |
4.2 Price Multiples
AMN's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. AMN is cheaper than 92.31% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of AMN indicates a rather cheap valuation: AMN is cheaper than 91.45% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 8.45 | ||
| EV/EBITDA | 7.06 |
4.3 Compensation for Growth
The excellent profitability rating of AMN may justify a higher PE ratio.
AMN's earnings are expected to decrease with -13.49% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)0.37
EPS Next 2Y-23.45%
EPS Next 3Y-13.49%
5. Dividend
5.1 Amount
AMN does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
AMN HEALTHCARE SERVICES INC
NYSE:AMN (5/3/2024, 7:04:00 PM)
After market: 59.53 0 (0%)59.53
-0.68 (-1.13%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap2.26B
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 7.3 | ||
| Fwd PE | 14.87 | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)0.37
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.2% | ||
| ROE | 25.35% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | 8.93% | ||
| PM (TTM) | 5.56% | ||
| GM | 32.98% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1.3
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.57 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 1.28 | ||
| Quick Ratio | 1.28 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-31.14%
EPS 3Y33.37%
EPS 5Y
EPS growth Q2Q
EPS Next Y-50.93%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-27.73%
Revenue growth 3Y16.55%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y